TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy

Triple-negative breast cancer (TNBC) is a heterogeneous, recurring cancer associated with a high rate of metastasis, poor prognosis, and lack of therapeutic targets. Although target-based therapeutic options are approved for other cancers, only limited therapeutic options are available for TNBC. Cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Desh Deepak, Yadav, Dharmendra Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389539/
https://www.ncbi.nlm.nih.gov/pubmed/34440080
http://dx.doi.org/10.3390/biomedicines9080876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389539/
https://www.ncbi.nlm.nih.gov/pubmed/34440080
http://dx.doi.org/10.3390/biomedicines9080876

Ejemplares similares